Millions of Americans have endured “the long goodbye,” helplessly watching loved ones succumb to Alzheimer's disease. New treatments offer hope in slowing its progression, but their success depends on accurate diagnosis. Until Medicare revises its coverage policy for the diagnostics that facilitate these treatments, very few seniors and their families will benefit.
Read Full Article »
